Critical Diagnostics Widens its Footprint in the Asia Pacific Region for its Cardiac Biomarker ST2

SAN DIEGO--(BUSINESS WIRE)--Critical Diagnostics, a U.S.-based biomarker company focused on cardiovascular diseases, today announced that it continues to expand its presence in the Asia Pacific region with the addition of two distribution partners.

MORE ON THIS TOPIC